Six researchers affiliated with Karolinska Institutet have been awarded funding in the Swedish Childhood Cancer Fund's latest call for research positions, with a total allocation of SEK 57 million. The funded projects include initiatives aimed at improving chemotherapy for children with leukemia, as well as studies seeking to better understand relapse in acute lymphoblastic leukemia.
Each year, the Swedish Childhood Cancer Fund announces research positions in the field of pediatric oncology. In the current funding cycle, SEK 57 million has been distributed across 23 research positions.
Six of these appointments have been granted to researchers at, or associated with, Karolinska Institutet:
Sean Rudd , principal researcher at the Department of Oncology-Pathology , has been awarded a full-time senior research position in childhood cancer for a period of six years. His work focuses on enhancing chemotherapy treatments for pediatric leukemia patients.
Adam van Niekerk , assistant professor at the Department of Clinical Neuroscience , has received a four-year full-time research position in childhood cancer, along with operational funding. His research investigates the development of anesthesia-free brain MRI techniques for children, utilizing advanced wearable sensor technology.
Vasilios Zachariadis , researcher at the Department of Oncology-Pathology , has been granted protected research time for clinicians (three months annually over three years). His project is entitled Tracing the Cellular Origins of Treatment Persistence and Relapse in Childhood Acute Lymphoblastic Leukemia.
Ann Nordgren , professor at the Department of Molecular Medicine and Surgery , has been awarded a doctoral studentship for clinicians. Her research focuses on congenital malformations and genetic predispositions associated with childhood cancer.
Josefine Eriksson Naili , docent at the Department of Women's and Children's Health , has received a doctoral studentship for clinicians. Her work examines long-term physical function and activity levels following limb-sparing surgical procedures.
Inês Neves, researcher at the Department of Women's and Children's Health , has been granted a two-year postdoctoral fellowship in the United States. Her research explores metabolic reprogramming as a mechanism of therapeutic resistance in diffuse midline glioma.
